4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001610717-24-000123
Options or other derivatives
- See Remarks acquired 308,940 shares (grant or award)
From the SEC's structured data for this filing
Aligos Therapeutics, Inc. Filed Acc 0001610717-24-000123
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…